These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1664512)

  • 1. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells.
    Raymond WA; Leong AS
    Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.
    Böcker W; Bier B; Freytag G; Brömmelkamp B; Jarasch ED; Edel G; Dockhorn-Dworniczak B; Schmid KW
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):323-30. PubMed ID: 1384227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast.
    Amenta PS; Hadad S; Lee MT; Barnard N; Li D; Myers JC
    J Pathol; 2003 Mar; 199(3):298-308. PubMed ID: 12579531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basement membrane and apocrine epithelial antigens in differential diagnosis between tubular carcinoma and sclerosing adenosis of the breast.
    Ekblom P; Miettinen M; Forsman L; Andersson LC
    J Clin Pathol; 1984 Apr; 37(4):357-63. PubMed ID: 6323547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.
    Prasad ML; Hyjek E; Giri DD; Ying L; O'Leary JJ; Hoda SA
    Am J Surg Pathol; 1999 Feb; 23(2):176-81. PubMed ID: 9989844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions.
    Tsubura A; Shikata N; Inui T; Morii S; Hatano T; Oikawa T; Matsuzawa A
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):133-9. PubMed ID: 2838950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.
    Wetzels RH; Holland R; van Haelst UJ; Lane EB; Leigh IM; Ramaekers FC
    Am J Pathol; 1989 Mar; 134(3):571-9. PubMed ID: 2466404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of monoclonal antibodies against human carcinosarcoma cell line for identification of myoepithelium and basement membrane.
    Meenakshi A; Udayachander M; Schol DJ; Hageman P; Hilgers J
    Clin Immunol Immunopathol; 1988 Jul; 48(1):78-84. PubMed ID: 2838204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
    Gusterson BA; Warburton MJ; Mitchell D; Ellison M; Neville AM; Rudland PS
    Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin-rich (myoepithelial) cells in ductal carcinoma-in-situ of the breast.
    Bussolati G; Botta G; Gugliotta P
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 34(3):251-9. PubMed ID: 6108644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
    Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
    Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation.
    Papotti M; Gugliotta P; Ghiringhello B; Bussolati G
    Histopathology; 1984 Nov; 8(6):963-75. PubMed ID: 6098550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin production and fibronectin immunoreactivity in breast carcinomas.
    Gorczyca W; Holm R; Nesland JM
    Anticancer Res; 1993; 13(4):851-8. PubMed ID: 8394677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study.
    Siegal GP; Barsky SH; Terranova VP; Liotta LA
    Invasion Metastasis; 1981; 1(1):54-70. PubMed ID: 6329985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.
    Damiani S; Ludvikova M; Tomasic G; Bianchi S; Gown AM; Eusebi V
    Virchows Arch; 1999 Mar; 434(3):227-34. PubMed ID: 10190302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.